Patient and Caregiver Priorities in Neuro-oncology Care

Get Involved

Patient and Caregiver Priorities in Neuro-oncology Care

Study Purpose

This study is being done to identify patient and caregiver burdens regarding their experience with diagnosis and treatment of CNS tumors. These results will help doctors find areas where patients and caregivers may need more support.

Recruitment Criteria

Accepts Healthy Volunteers Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms	Yes
Study Type An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes. An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes. Searching Both is inclusive of interventional and observational studies.	Observational
Eligible Ages	18 Years and Over
Gender	All

More Inclusion & Exclusion Criteria

Inclusion Criteria:

- * Age ≥ 18 years.

- Diagnosis of primary or metastatic CNS tumor with a primary caregiver, should patient wish to involve one.

- Willing and able to participate in a semi-structured interview lasting approximately 60 minutes.

Dyad interviews conducted for participants who elect to involve a caregiver.

- Willing and able to participate in a single follow-up interview.

Dyad follow up interviews conducted for participants who elect to involve a caregiver.

Exclusion Criteria:

- * Uncontrolled and/or intercurrent illness which limits participation in study interview.

- Vulnerable populations: pregnant or nursing persons, prisoners, or persons lacking capacity for understanding.

- Unable to read and speak English.

- Note: English does not need to be primary language.

Trial Details

Trial ID: This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.	NCT06676306
Phase Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans. Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data. Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.
Lead Sponsor The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.	Mayo Clinic
Principal Investigator The person who is responsible for the scientific and technical direction of the entire clinical study.	Ugur T. Sener, MD
Principal Investigator Affiliation	Mayo Clinic in Rochester
Agency Class Category of organization(s) involved as sponsor (and collaborator) supporting the trial.	Other
Overall Status	Recruiting
Countries	United States
Conditions The disease, disorder, syndrome, illness, or injury that is being studied.	Malignant Central Nervous System Neoplasm, Metastatic Malignant Neoplasm in the Central Nervous System
Study Website:	View Trial Website

Additional Details

PRIMARY OBJECTIVES:

I. Describe the patient experience and characterize the symptom burden related to primary or metastatic central nervous system tumors.

II. Describe the caregiver experience and caregiver needs related to patients with primary or metastatic central nervous system tumors.

III. Establish which interventional treatment outcomes are important to patients and caregivers, within a wider understanding of their lived experience with CNS tumors and their treatment.

OUTLINE: This is an observational study. Patients and their caregivers participate in interviews on study. Patients also have their medical records reviewed on study.

Arms & Interventions

Arms

: Observational

Patients and their caregivers participate in interviews on study. Patients also have their medical records reviewed on study.

Interventions

Other: - Non-Interventional Study

Non-Interventional Study

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

Mayo Clinic in Rochester, Rochester, Minnesota

Status

Recruiting

Address

Mayo Clinic in Rochester

Rochester, Minnesota, 55905

Site Contact

Clinical Trials Referral Office

[email protected]

855-776-0015